| CAS | Product Name | MF |
|
37806-44-3
|
4-(2-Methylpropoxy)benzenemethanamine hydrochloride
|
C11H18ClNO
|
|
869296-13-9
|
T-26c
|
C24H21N3O6S
|
|
92950-40-8
|
2'-ACETYLTAXOL
|
C49H53NO15
|
|
2763157-90-8
|
Pyrido[4,3-d]pyrimidin-4(3H)-one, 5,7-dichloro-8-fluoro-2-(methylthio)-
|
C8H4Cl2FN3OS
|
|
1093072-86-6
|
Desfluoro Citalopram Oxalate
|
C22H24N2O5
|
|
103213-42-9
|
(3,5-DIIODO-TYR1)-DAGO ACETATE SALT
|
C26H33I2N5O6
|
|
1241725-60-9
|
3-(FluoroMethyl)piperidine HCl
|
C6H13ClFN
|
|
129821-76-7
|
DSPACER CEP
|
C35H45N2O6P
|
|
28770-01-6
|
3-Oxazolidineethanol,2-(1-methylethyl)-(9CI)
|
C8H17NO2
|
|
1266118-78-8
|
1-Piperidinecarboxylic acid, 4-(6-chloro-2-pyridinyl)-, 1,1-dimethylethyl ester
|
C15H21ClN2O2
|
|
1094073-72-9
|
4,4-DIFLUOROHEXAHYDRO-1H-AZEPINE HYDROCHLORIDE
|
C6H12ClF2N
|
|
5632-47-3
|
1-nitrosopiperazine
|
C4H9N3O
|
|
942437-37-8
|
3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl-
|
C19H19FN4O2
|
|
14678-93-4
|
5-AMINO-1-(4-METHYLPHENYL)-1H-PYRAZOLE-&
|
C11H11N3O2
|
|
42308-28-1
|
5-methyl-1,1'-biphenyl-2-amine
|
C13H13N
|
|
39096-01-0
|
2-HYDROXY-N,N-DIETHYLACETAMIDE
|
C6H13NO2
|
|
136647-02-4
|
4-[(Diphenylmethoxy)methyl]-1-[3-(4-methoxyphenyl)propyl]-piperidinehydrochloride
|
C29H35NO2.HCl
|
|
60195-70-2
|
Yuanhuacine
|
C37H44O10
|
|
14590-52-4
|
(1S,2S)-2-Methylcyclopropane-1-carboxylic acid
|
C5H8O2
|
|
221121-37-5
|
4-(4-FLUORO-PHENYL)-3-OXO-BUTYRIC ACID ETHYL ESTER
|
C12H13FO3
|
|
33118-86-4
|
6-bromo-3-methylbenzofuran
|
C9H7BrO
|
|
78385-84-9
|
4-fluorobicyclo[2.2.2]octane-1-carboxylic acid
|
C9H13FO2
|
|
1414629-40-5
|
1,3-bis(4-carboxyphenyl)imidazoliumchloride
|
C17H13ClN2O4
|
|
6259-19-4
|
dibenzo[b,d]thiophene-3,7-diamine 5,5-dioxide
|
C12H10N2O2S
|
|
1137869-91-0
|
5-Bromo-1-fluoro-3-methoxy-2-nitrobenzene
|
C7H5BrFNO3
|
|
359424-42-3
|
Ethyl 3-(3,5-difluorophenyl)-3-oxopropanoate
|
C11H10F2O3
|
|
1400264-85-8
|
tert-Butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate hydrate
|
C10H17F2NO4
|
|
198483-36-2
|
CHOLECYSTOKININ OCTAPEPTIDE (1-6) (DESULFATED)
|
C36H47N7O10S2
|
|
183198-48-3
|
N-Methyl Iso Desloratadine
|
C20H21ClN2
|
|
16009-86-2
|
TIN (II) ACETYLACETONATE
|
C10H14O4Sn
|
|
213018-42-9
|
H-GLY-TYR-PRO-GLY-LYS-PHE-OH
|
C33H45N7O8
|
|
151151-29-0
|
H-HIS-LYS-OH HBR
|
C12H22BrN5O3
|
|
515823-30-0
|
Tetramethylammonium trifluoromethanethiolate
|
C5H12F3NS
|
|
18777-73-6
|
Sieboldin
|
C21H24O11
|
|
70639-76-8
|
1-(4-Ethylphenyl)-2-methyl-2-propen-1-one
|
C12H14O
|
|
448895-60-1
|
Benzene, 1,1'-(1,2-ethynediyl)bis[3,5-dibromo-
|
C14H6Br4
|
|
182122-08-3
|
(3aS,3'aS,8aR,8'a'R)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
|
C23H20N2O2
|
|
874289-51-7
|
5-(TERT-BUTYLCARBAMOYL)-2-FLUOROBENZENEBORONIC ACID
|
C11H15BFNO3
|
|
82755-59-7
|
(trans)-4-(((trans)-4-(aminomethyl)cyclohexanecarboxamido)methyl) cyclohexanecarboxylic
|
C16H28N2O3
|
|
1035351-06-4
|
1-{[(1,1-diMethylethyl)oxy]carbonyl}-3-hydroxyazetidine-3-carboxylic acid
|
C9H15NO5
|
|
1619931-27-9
|
3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-
|
C27H27N5O3
|
|
73724-48-8
|
Fmoc-Thr-Obzl
|
C26H25NO5
|
|
168332-13-6
|
(S)-GNA-T-phosphoramidite
|
C38H47N4O7P
|
|
12225-86-4
|
REACTIVE ORANGE 14
|
C19H12Cl2N8O9S2
|
|
50692-78-9
|
(R)-Methyl 3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate
|
C10H19NO5
|
|
1056113-50-8
|
3-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-dibenzofuran
|
C18H19BO3
|
|
439089-27-7
|
439089-27-7
|
C18H26BrNO2S
|
|
184473-24-3
|
PYRAZOLO[1,5-A]PYRIDIN-6-OL
|
C7H6N2O
|
|
89692-53-5
|
1,2-Benzisoxazol-3-amine,6-chloro-(9CI)
|
C7H5ClN2O
|
|
2432-77-1
|
S-Methyl thiohexanoate
|
C7H14OS
|
|
1018899-03-0
|
β-L-Xylopyranoside, Methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-1-thio-, 2,3,4-triacetate,(5S)-
|
C27H31ClO8S
|
|
356068-98-9
|
Sunitinib iMpurity
|
C12H19N3O2
|
|
20151-47-7
|
8-METHYL-3,4-DIHYDROQUINOLIN-2(1H)-ONE
|
C10H11NO
|
|
2245708-24-9
|
2,5-bis((hydrazinyloxy)carbonyl)benzene-1,4-diol
|
C8H10N4O4
|
|
4282-46-6
|
3-(4-NITROPHENYL)PYRIDINE
|
C11H8N2O2
|
|
1274892-60-2
|
N3-PEG7-OH
|
C14H29N3O7
|
|
154590-66-6
|
(S)-N-((3-(3-Fluoro-4-piperazin-1-ylphenyl)-2-oxooxazolidin-5-yl)Methyl)-acetaMide
|
C16H21FN4O3
|
|
507276-74-6
|
Boc-D-Tyr(tBu)-OH
|
C18H27NO5
|
|
545445-10-1
|
3,3-Dichloro-1-(4-iodophenyl)piperidin-2-one
|
C11H10Cl2INO
|
|
948349-66-4
|
4-bromo-3-ethoxymethyl-benzoic acid ethyl ester
|
C12H15BrO3
|
|
688363-79-3
|
2-(Benzyloxy)-1-broMo-3-nitrobenzene
|
C13H10BrNO3
|
|
206055-70-1
|
9-[2,5-Anhydro-4-C-(hydroxymethyl)-alpha-L-lyxofuranosyl]-9H-purin-6-amine
|
C11H13N5O4
|
|
27750-13-6
|
HYDROXYCITRIC ACID LACTONE, (-)-(P)
|
C6H6O7
|
|
2288710-66-5
|
(4-(4-Methylthiazol-5-yl)phenyl)methanamine hydrochloride
|
C11H13ClN2S
|
|
886762-68-1
|
2,6-DIFLUORO-4-IODOANISOLE
|
C7H5F2IO
|
|
898537-18-3
|
D-Glucitol, 1,5-dideoxy-1,5-epithio-1-C-[5-[(4-ethoxyphenyl)Methyl]-2-Methoxy-4-Methylphenyl]-, (1S)-
|
C23H30O6S
|
|
178949-81-0
|
AMYLOID BETA-PROTEIN (33-42)
|
C41H74N10O11S
|
|
192377-94-9
|
PYR-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-OH
|
C143H226N38O39S
|
|
58610-61-0
|
2-Pyridinecarboxylicacid, 5-cyano-1,6-dihydro-4-methyl-6-oxo-, ethyl ester
|
C10H10N2O3
|
|
129809-09-2
|
AC-LEU-ASP-GLN-TRP-PHE-GLY-NH2
|
C39H51N9O10
|
|
917397-92-3
|
1-(5-bromopyridin-2-yl)-2,2,2-trifluoroethanol
|
C7H5BrF3NO
|
|
2116240-24-3
|
5H-Imidazo[4,5-c]pyridine-2,5-dicarboxylic acid, 1,4,6,7-tetrahydro-1-methyl-, 5-(1,1-dimethylethyl) 2-methyl ester
|
C14H21N3O4
|
|
59219-71-5
|
3 5 5-TRIMETHYLHEXYL 3 5 5-TRIMETHYL-
|
C18H36O2
|
|
137348-10-8
|
HYPERCALCEMIA OF MALIGNANCY FACTOR (107-139) (HUMAN)
|
C142H228N42O58
|
|
306745-64-2
|
4-bromo-N-cyclopropylbenzamide
|
C10H10BrNO
|
|
121880-96-4
|
CHOLECYSTOKININ OCTAPEPTIDE (1-5) (DESULFATED)
|
C31H38N6O9S
|
|
171783-05-4
|
CROSSTIDE
|
C48H77N17O17
|
|
59456-70-1
|
NIKKOMYCIN Z
|
C20H25N5O10
|
|
178823-45-5
|
H-GLU-ASN-PRO-VAL-VAL-HIS-PHE-PHE-LYS-ASN-ILE-VAL-THR-PRO-ARG-THR-PRO-OH
|
C93H143N25O24
|
|
1599466-90-6
|
Binap Pd G4
|
C58H47NO3P2PdS
|
|
1646321-63-2
|
4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoicacidhydrochloride
|
C25H31ClN2O4
|
|
1380327-56-9
|
3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)oxetane-3-carboxylic acid
|
C19H17NO5
|
|
874219-33-7
|
4-FLUORO-3-(PHENYLCARBAMOYL)BENZENEBORONIC ACID
|
C13H11BFNO3
|
|
109481-23-4
|
PYR-GLN-OH
|
C10H15N3O5
|
|
30804-52-5
|
N-Acetyl-L-thyroxine Ethyl Ester
|
C19H17I4NO5
|
|
108783-02-4
|
(2-CYANOETHOXY)-2-(2''-O-1,1''-DIMETHOXYTRITYLOXYETHYLSULFONYL)- ETHOXY-N,N-DIISOPROPYLAMINOPHOSPHINE)
|
C34H45N2O7PS
|
|
4974-59-8
|
Ethanone, 2,2-dichloro-1-(4-methylphenyl)- (9CI)
|
C9H8Cl2O
|
|
1207609-52-6
|
6-Chloro-3-fluoro-pyridine-2-carbonitrile
|
C6H2ClFN2
|
|
133878-93-0
|
4'-(diphenylamino)-[1,1'-biphenyl]-4-carbaldehyde
|
C25H19NO
|
|
827596-80-5
|
PEG-30 DIPOLYHYDROXYSTEARATE
|
C20H40O4
|
|
1411910-25-2
|
10-(4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-10H-phenoxazine
|
C33H22N4O
|
|
2135576-73-5
|
Vortioxetine Impurity 8
|
C19H22N2OS
|
|
91575-26-7
|
H-Gly-Arg-Gly-Asp-Ser-Pro-Cys-OH
|
C25H42N10O11S
|
|
2139348-60-8
|
POMALIDOMIDE-PEG1-CO2H
|
C18H19N3O7
|
|
118691-43-3
|
atrial natriuretic peptide, frog
|
C103H165N37O34S3
|
|
2360851-29-0
|
4(3H)-Quinazolinone, 7-(cyclopropylmethoxy)-5-fluoro-2-[[(trans-4-hydroxycyclohexyl)thio]methyl]-
|
C19H23FN2O3S
|
|
1290540-34-9
|
Nonanedioic acid mono-tert-butyl ester
|
C13H24O4
|
|
68259-00-7
|
methyl 1-methyl-4-[(methylphenylhydrazono)methyl]pyridinium sulphate
|
C15H19N3O4S
|
|
1116085-99-4
|
Phe-Lys(Trt)-PAB
|
C41H44N4O3
|
|
71140-70-0
|
5-(Diphenylphosphinyl)pentanoic Acid
|
C17H19O3P
|